FindTrial
Sign In

AN INVESTIGATOR INITIATED STUDY TO OBSERVE AND EVALUATE THE INCIDENCE OF EGFR MUTATIONS IN ADULT INDIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER

AN INVESTIGATOR INITIATED, MULTI-CENTRIC, RETROSPECTIVE, OBSERVATIONAL STUDY TO EVALUATE THE INCIDENCE OF EGFR MUTATIONS IN ADULT INDIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/05/002665
Enrollment
150
Registered
2012-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Non-small cell lung Cancer

Interventions

None listed

Sponsors

Dr Senthil Rajappa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with non-small cell lung Cancer. 2. Subjects of Physicians who are willing to share their subjectsâ?? data for this study. 3. Ethics Committeeâ??s permission to conduct the analysis on a retrospective manner without the physical consent of the subjects who have contributed to the existing data from their respective institutions

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Incidence of EGFR mutationsTimepoint: 10 Months—

Secondary

MeasureTime frame
ï?? Types of mutations - incorrelation with demography, clinical parameters, etc. of the following: â?¢ % of Exon 19 Deletions â?¢ % of EGFR L858R (Exon 21) mutations â?¢ % of EGFR T790M (Exon 20) mutations â?¢ % of EGFR L861Q (Exon 21) mutations â?¢ % of EGFR G719X (Exon 18) mutations â?¢ % of EGFR S7681 (Exon 20) mutations â?¢ % of Exon 20 Insertions Timepoint: After Ten Months—

Countries

India

Contacts

Public ContactNagalakshmi

Indo-American Cancer institute & Research Centre

siddharth142@sify.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026